Actions for CADTH Canadian Drug Expert Committee final recommendation Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication [electronic resource] : type 2 diabetes

Email RIS file
Bookmark
Report an Issue

CADTH Canadian Drug Expert Committee final recommendation Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication [electronic resource] : type 2 diabetes

Published
[S.l.] : Canadian Agency for Drugs and Technologies in Health, 2016.
Access Online

Availability

I Want It
I Want It

Finding items...

Restrictions on Access
License restrictions may limit access.
Genre(s)
Note
Title from content provider.
View MARC record | catkey: 44546020